Proscia

Proscia is an AI-driven digital pathology platform that rewires pathology for precision medicine. It offers solutions for AI-powered cancer diagnostics and drug development, recognized as a top performer in KLAS ratings.

Claim this tool

2Views

At a glance

Pricing

Likely Not Free

Free tier

API

Skill level

Technical

About

What is Proscia?

Proscia offers the Concentriq platform, an enterprise digital pathology solution designed to accelerate research and diagnostic workflows. Rated #1 by customers in 2026 Best in KLAS, Concentriq provides purpose-built products like Concentriq LS for life sciences to fast-track biomarker discovery and clinical trials, and Concentriq AP for academic medical centers and labs to go fully digital. Concentriq AP-Dx is FDA-cleared for primary diagnosis, offering an intuitive experience for case interpretation and management. The platform also includes an AI Portfolio and Proscia Aperture, a precision medicine solution that turns data into insights at the moment of diagnosis, supporting drug development and real-world evidence generation. Proscia aims to improve diagnostic quality, increase efficiency, and accelerate precision medicine with its AI solutions.

Best used for

Ideal for doctors and researchers who need to accelerate biomarker discovery, digitize pathology labs, and manage diagnostic cases efficiently. Especially valuable for those seeking AI-powered solutions for cancer diagnostics and drug development in precision medicine.

Common actions

diagnose cancer

develop drugs

manage pathology cases

analyze pathology data

digitize lab workflows

research

Capabilities

Key features

Enterprise digital pathology platform
AI portfolio for cancer diagnostics
Precision medicine solution
FDA-cleared primary diagnosis
Accelerate R&D workflows
Digitize lab operations

Target Audience

doctor

Integrations

Not yet documented

Pricing & Plans

Likely Not Free

Contact for Pricing

FAQs

What is the Concentriq platform?

Concentriq is Proscia's enterprise digital pathology platform. It offers purpose-built products like Concentriq LS for life sciences research, Concentriq AP for digitizing labs, and Concentriq AP-Dx, which is FDA-cleared for primary diagnosis in the United States.

Is Proscia's Concentriq AP-Dx approved for all diagnostic uses?

Concentriq AP-Dx is FDA-cleared for primary diagnosis in the U.S. with specific scanner models and is licensed in Canada and CE-marked under the EU IVDR. However, it is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens.

Are Proscia's AI applications for diagnostic use?

Proscia's AI applications are currently available for research use only. Similarly, Concentriq AP and Concentriq LS are designated for Research Use Only and are not intended for use in diagnostic procedures.

Trending

Subcategories trending in Wellness & Lifestyle

Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking Home & Real Estate

Trending

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce